Sun
Pharmaceutical Industries, which has cash balance of $1.3 billion as on March
this year including its subsidiary Taro Pharmaceutical Industries, was in talks
with banks to raise funds for the acquisition of Swedish firm Meda
Pharmaceuticals for up to $6 billion in June. However, on account of sharp
depreciation of rupee in June and patent settlement worth $550 million in the
US, has opted out from the race. Get Free MCX Tips, Stock Tips, Forex Tips & NCDEX Tips,Commodity Tips, Share Tips, commodity tips free trial, nifty free tips, commodity trading tips, shares tips, Share Market Tips, Stock Market Tips, free stock tips on mobile, Stock trading tips, Intraday Tips. or login http://www.epicresearch.co/
No comments:
Post a Comment